Aref Matin - 02 Nov 2023 Form 4 Insider Report for JOHN WILEY & SONS, INC. (WLY)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
06 Nov 2023, 18:26:02 UTC
Prior SEC filing
05 Jul 2023
Next SEC filing
02 May 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Marjorie Pierre-Merritt, Attorney-In-Fact

Key filing fact

Aref Matin filed Form 4 for JOHN WILEY & SONS, INC. (WLY) on 06 Nov 2023.

Key facts

  • This page summarizes Aref Matin's Form 4 filing for JOHN WILEY & SONS, INC. (WLY).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 06 Nov 2023, 18:26.

Change

  • Previous filing in this sequence was filed on 05 Jul 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

WLY transaction Derivative

Non-Qualified Stock Options (right to buy)

Award

Transaction value
$0
Shares
+20,000
Change %
Price
$0.000000
Shares after
20,000
Date
02 Nov 2023
Ownership
Direct
Underlying class
Class A Common
Underlying amount
20,000
Exercise price
$35.00
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Non-Qualified stock options granted at a premium price of $35.00.

Footnote F2

Non-qualified stock options granted under the John Wiley & Sons, Inc. 2022 Omnibus Stock and Long-Term Incentive Plan to vest 10% on 4/30/2024; 20% on 4/30/2025, 30% on 4/30/2026 and 40% on 4/30/2027, and are subject to forfeiture per the terms and conditions of the grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .